A study revealed that two forms of androgen deprivation therapy (ADT) for prostate cancer differently impact coronary artery plaque progression, with one leading to significantly more plaque growth. This finding is crucial as it highlights potential cardiovascular risks associated with specific ADT types, advising content creators to emphasize the importance of discussing these risks with patients when covering prostate cancer treatments.
Read the full article at MedPage Today
This is a brief trending article summary.
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



